Anti-Candidal Marine Natural Products: A Review

Arumugam Ganeshkumar1,2, Juliana Caparroz Gonçale1, Rajendran Rajaram3

  • 1Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, Sao Paulo State University (UNESP), Sao Jose dos Campos 12245-000, Brazil.

Insights

Marine natural products show promise in combating Candida infections, including drug-resistant strains. Sponges yield compounds like hippolide J, offering new therapeutic avenues against candidiasis.

Area of Science:

  • Marine Biology
  • Microbiology
  • Natural Product Chemistry

Background:

  • * *Candida* species are opportunistic pathogens causing infections, particularly in immunocompromised individuals.
  • * *Candida albicans* is the most common species, but drug-resistant strains like *Candida auris* pose a growing threat.
  • * Antifungal resistance limits treatment options for candidiasis.

Purpose of the Study:

  • * To review the potential of marine natural products in controlling *Candida* species proliferation and metabolism.
  • * To highlight marine organisms and compounds with anti-candidal activity.
  • * To explore mechanisms of action and synergistic effects of marine products.

Main Methods:

  • * Literature review of studies on marine natural products and their anti-candidal activity since the 1980s.
  • * Analysis of compounds derived from sponges, algae, sea cucumbers, bacteria, and fungi.
  • * Examination of specific compounds, such as hippolide J from the sponge *Hippospongia lachne*.

Main Results:

  • * Marine natural products, especially from sponges, demonstrate significant inhibitory activity against various *Candida* species, including resistant strains.
  • * Terpenoids, sterols, and alkaloids from sponges are potent anti-candidal agents.
  • * Hippolide J showed strong activity against *Candida albicans*, *Candida parapsilosis*, and *Candida glabrata*.

Conclusions:

  • * Marine-derived compounds can effectively control *Candida* genus microorganisms.
  • * These natural products offer a promising source for developing novel anti-candidal therapies.
  • * Further research into mechanisms and synergy can guide new drug design.

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...